Bradford Teaching Hospitals has shared that artificial intelligence software called Annalise.ai is being utilised in its radiology department with the aim of enhancing diagnostic accuracy, efficiency and patient outcomes.
The software is being used to provide “a second set of eyes” by being applied to chest X-rays, with the trust highlighting that findings such as lung nodules and pneumonia “can often be subtle, and risk being overlooked in certain situations.”
Annalise.ai is said to be able to “detect up to 124 findings on chest X-rays within seconds”, assisting radiology reporters in prioritising urgent cases and enabling important findings to be highlighted to the team at a quicker pace. It includes a number of features such as a customisable user interface with “a confidence bar displays the likelihood of the findings and the AI model’s uncertainty” to help clinicians with interpretations.
Ashley Isherwood, principal superintendent radiographer at the trust, called the technology “a great development for our service as it can directly impact patient care” and added that it “has the potential to help with collapsed lungs and early cancer detection allowing improved patient outcomes.”
In other news from the area, we previously highlighted how the Bradford District Care NHS Foundation Trust’s iCare innovation development programme is funding innovative projects to enhance patient care, including a sensory and edible garden, a therapeutic intervention for young people, and staff training videos.
We also shared an update from Bradford Teaching Hospitals around its Virtual Royal Infirmary Programme, which focuses on delivering digital patient education tools across a range of specialties including paediatric surgery and fracture care.
On artificial intelligence, we noted that NHS North Central London ICB and the Islington GP Federation are trialling an AI solution utilising WhatsApp for cervical cancer screening appointments, with the aim of increasing uptake in cervical cancer screening particularly amongst underserved populations.
We also shared the news that South Tyneside and Sunderland NHS Foundation Trust, Newcastle University and Roche Products Limited are collaborating in the hopes of using artificial intelligence to support treatment for diabetic retinopathy, by exploring how AI could help identify biomarkers on 3D retina images.
